Approval · Notice of Compliance 12070 · 2011
OLMETEC PLUS: Notice of Compliance 12070
Issued February 15, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12070
- Date
- February 15, 2011
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Angiotensin II AT1 receptor blocker / Diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OLMETEC PLUS | 02319616 | Marketed |
| OLMETEC PLUS | 02319624 | Marketed |
| OLMETEC PLUS | 02319632 | Marketed |
Medicinal ingredients
- OLMESARTAN MEDOXOMIL 20 MG per TAB
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- OLMESARTAN MEDOXOMIL 40 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB